Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_636_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Preface
- •Contents
- •Contributors
- •Puborectalis Muscle
- •Iliococcygeus Muscle
- •Pubococcygeus Muscle
- •Mesorectum
- •Presacral Fascia
- •Retrosacral Fascia
- •Waldeyer’s Fascia
- •Denonvilliers’ Fascia
- •Lateral Ligaments
- •Anorectal Spaces
- •Perianal Space
- •Intersphincteric Space
- •Submucous Space
- •Ischioanal/Ischiorectal Space
- •Supralevator Space
- •Anal Canal Epithelium
- •Internal Anal Sphincter
- •Conjoined Longitudinal Muscle
- •External Anal Sphincter
- •Perineal Body
- •Pelvic Floor Muscles
- •Retrorectal Space
- •Rectal Blood Supply
- •Superior Rectal Artery
- •Middle Rectal Artery
- •Inferior Rectal Artery
- •Cecum
- •The Appendix
- •Ascending Colon
- •Transverse Colon
- •Descending Colon
- •Sigmoid Colon
- •Rectosigmoid Junction
- •Blood Supply
- •Superior Mesenteric Artery
- •Inferior Mesenteric Artery
- •Venous Drainage
- •Lymphatic Drainage
- •Nervous Innervation
- •Embryology
- •Non-rotation
- •Malrotation
- •Reversed Rotation
- •Omphalocele
- •Internal Hernias
- •Proximal Colon Duplication
- •Meckel’s Diverticulum
- •Hirschsprung’s Disease
- •Anorectal Malformations
- •Anal Stenosis
- •Membranous Atresia
- •Anal Agenesis
- •Anorectal Agenesis
- •Rectal Atresia or “High Atresia”
- •Persistent Cloaca
- •2: Colonic Physiology
- •Colonic Anatomy
- •Introduction
- •Colonic Wall Anatomy
- •Colonic Epithelial Cell Types
- •Colonic Flora
- •Electrolyte Regulation and Water Absorption
- •Short-Chain Fatty Acid Absorption
- •Secretory Role of the Colonic Epithelium
- •Regulation of Electrolyte and Water Absorption and Secretion
- •Colonic Innervation
- •Colonic Motility
- •Cellular Basis of Motility
- •Motility Patterns and Measurement
- •Introduction
- •Normal Continence
- •Rectal Capacity
- •Structural Considerations
- •Normal Defecation
- •Obstructed Defecation
- •Functional Anorectal Pain
- •4: Endoscopy
- •Introduction
- •The Complete Anorectal Examination
- •Patient Position
- •Prone Jackknife
- •Left Lateral
- •Digital Rectal Examination
- •Anoscopy/Proctoscopy
- •Anoscopy
- •Proctoscopy
- •Flexible Endoscopy
- •Flexible Endoscopic Insertion Techniques
- •Torque
- •Dithering/Jiggle
- •Slide-By
- •Special Considerations
- •The Patient Requiring Antibiotics
- •The Anticoagulated Patient
- •Incomplete Colonoscopy
- •Procedure
- •The Endoscopy Suite
- •Instruments
- •Sedation
- •Nitrous Oxide
- •Ketamine
- •Propofol
- •Colonoscopy Technique
- •Anal Intubation
- •Sigmoid Colon
- •Sigmoid-Descending Junction
- •Descending Colon
- •Splenic Flexure
- •Transverse Colon
- •Hepatic Flexure
- •Cecum
- •Patient Position
- •Abdominal Pressure
- •Sigmoidoscopy
- •Colonoscopy
- •Bowel Preparation
- •Ileocecal Valve Intubation
- •Terminal Ileum
- •Alternate Techniques
- •Chromocolonoscopy (Chromoendoscopy)
- •Full-Spectrum Endoscopy
- •Complications
- •Sedation Complications
- •Vasovagal/Cardiac Arrhythmia
- •Pulmonary
- •Procedural Complications
- •Splenic Injury
- •Perforation
- •Post-polypectomy Syndrome
- •Bleeding
- •Infectious Complications
- •Simulation
- •Documentation
- •Quality
- •PillCam Endoscopy
- •Introduction
- •Polypectomy Techniques
- •Endoscopic Mucosal Resection
- •Endoscopic Submucosal Dissection
- •Combined Endo-Laparoscopic Surgery (CELS)
- •Major Abdominal Surgery
- •Anorectal Surgery
- •Preoperative Testing
- •Laboratory Studies
- •Electrocardiogram
- •Chest X-ray
- •Initial Workup
- •Who Needs Additional Testing?
- •Preoperative “Optimization”
- •Coronary Stent Management
- •AICD/Pacemaker Management
- •COPD
- •Obstructive Sleep Apnea (OSA)
- •Diabetes
- •Obesity
- •Malnutrition
- •Solid Organ Transplant Recipients
- •Substance Abuse
- •Alcohol
- •Tobacco
- •Opioids
- •Medications
- •Anticoagulation
- •Immunosuppressive Agents
- •Chemotherapy
- •Introduction
- •Preoperative Management
- •Patient Education
- •Intraoperative Pathway
- •Minimally Invasive Colorectal Surgery
- •Intraoperative Fluid Administration
- •Analgesia
- •Venous Thromboembolism (VTE) Prophylaxis
- •Postoperative Recovery
- •Analgesia
- •Intravenous Fluid Management
- •Venous Thromboembolism (VTE) Prophylaxis
- •Quality Pathway Evaluation Measures
- •Quality Improvement Measures
- •8: Postoperative Complications
- •Introduction
- •Ureteral Injury
- •Bladder Injury
- •Urethral Injury
- •IV Fluid Management
- •Wound Management
- •Bladder Management
- •Pain Management
- •Academic Medical Center
- •Wound Complications
- •Preoperative Considerations
- •Perioperative Interventions
- •Long-Term Complications
- •Genitourinary Complications
- •Fertility Complications
- •Bowel Dysfunction
- •9: Anastomotic Construction
- •Introduction
- •Surgical Staplers
- •Handsewn Anastomoses
- •Compression Anastomoses
- •Tension
- •Blood Supply
- •Prophylactic Drainage
- •Diversion
- •High-Risk Anastomoses
- •Abdominal Anastomoses
- •Small Bowel Anastomoses
- •Ileocolic Anastomoses
- •Pelvic Anastomoses
- •Stapled Colorectal Anastomoses
- •Handsewn Colorectal Anastomosis
- •Ileorectal Anastomosis
- •Neorectal Reservoirs
- •Handsewn Coloanal Anastomosis
- •Unanticipated Pelvic Anastomosis
- •Inadequate Colonic Length
- •Intraoperative Anastomotic Failure
- •10: Anastomotic Complications
- •Anastomotic Leak
- •Overview
- •Consequences
- •Prevention
- •Diagnosis
- •Treatment
- •Anastomotic Stricture
- •Anastomotic Bleeding
- •Introduction
- •Patient History
- •Levator Syndrome
- •Physical Examination
- •Abdominal Examination
- •Inguinal Examination
- •Digital Rectal Examination
- •Conclusion
- •12: Hemorrhoids
- •Anatomy
- •Etiology
- •Epidemiology
- •Clinical Presentation
- •History
- •Physical Examination
- •Treatment
- •Medical Management
- •Dietary
- •Topical Therapies
- •Oral Therapy
- •Rubber Band Ligation
- •Infrared Photocoagulation
- •Sclerotherapy
- •Excisional Hemorrhoidectomy-Closed Technique
- •Excisional Hemorrhoidectomy Open Technique (Milligan-Morgan)
- •Excisional Hemorrhoidectomy (Circumferential or Whitehead)
- •Urinary Retention
- •Postoperative Hemorrhage
- •Anal Stenosis
- •Postoperative Infection
- •Fecal Incontinence
- •Stapled Hemorrhoidopexy
- •Transanal Hemorrhoidal Dearterialization
- •Special Clinical Scenarios
- •Thrombosed External Hemorrhoid
- •Pregnancy
- •Crohn’s Disease
- •Immunocompromised Patients
- •13: Anal Fissure
- •Pathogenesis
- •Non-operative Treatment
- •Healing Rates in Acute Anal Fissure
- •Healing Rates in Chronic Anal Fissure
- •Topical
- •Nitroglycerin
- •Calcium Channel Blockers
- •Botulinum Toxin Type A
- •Operative Treatment
- •Anal Dilation
- •Anal Sphincterotomy (Technique)
- •Outcomes Between Closed and Open Anal Sphincterotomy
- •Extent of Sphincterotomy
- •Fissurectomy
- •Results of Sphincterotomy
- •Fissures Without Anal Hypertonicity
- •Crohn’s Disease
- •Conclusions
- •Pathophysiology
- •Anatomy
- •Etiology
- •Evaluation
- •Physical Examination
- •Imaging
- •Computed Tomography (CT)
- •Magnetic Resonance Imaging (MRI)
- •Endoanal Ultrasound (EAUS)
- •Transperineal Sonography (TP-US)
- •Treatment
- •Catheter Drainage
- •Postoperative Management
- •Complications
- •Immediate Postoperative Period
- •Misdiagnosis
- •Special Considerations
- •Necrotizing Anorectal Infection (Fournier’s Gangrene)
- •Diagnosis
- •Treatment
- •Outcomes
- •Anal Fistula
- •Etiology
- •Diagnosis
- •Fistulography
- •Endoanal Ultrasound
- •Magnetic Resonance Imaging
- •Treatment
- •Lay-Open Technique (Fistulotomy)
- •Setons
- •Advancement Flap
- •Technique
- •Technique
- •Fibrin Glue
- •Technique
- •Anal Fistula Plug
- •Technique
- •Novel Techniques
- •15: Complex Anorectal Fistulas
- •Introduction
- •Complex or Recurrent Cryptoglandular Fistulas
- •Surgical Treatment
- •Seton
- •Anal Flap
- •Anal Fistula Plug
- •Fibrin Glue
- •Outcomes
- •Seton
- •Advancement Flap
- •Anal Fistula Plug
- •Fibrin Glue
- •Rectourethral Fistulas
- •Surgical Treatment
- •Transanal Approach
- •Posterior Approach
- •Transperineal Approach
- •Transabdominal Approach
- •Outcome
- •Postoperative Fistulas
- •Surgical Treatment
- •Outcome
- •16: Rectovaginal Fistula
- •Obstetric Injury
- •Cryptoglandular Disease
- •Crohn’s Disease
- •Endorectal Repairs
- •Transperineal Repairs
- •Tissue Transposition Repairs
- •Martius Flap
- •Gracilis Muscle Transposition
- •Transvaginal Repairs
- •Transabdominal Repair
- •Alternate Repairs
- •Background
- •Etiology
- •Clinical Presentation/Diagnosis
- •Treatment
- •Non-operative Management
- •Operative/Excisional Management
- •Basic Procedures
- •Complex Procedures
- •Karydakis Flap
- •Cleft Lift Procedure (See Video 17.1)
- •Rhomboid/Limberg Flap (See Video 17.2)
- •Disease Recurrence
- •Hidradenitis Suppurativa
- •Etiology/Presentation/Diagnosis
- •Treatment
- •Medical Therapy
- •Surgical/Excisional Therapy
- •Introduction
- •Irritants
- •Steroid-Inducing Itching
- •Infectious
- •Dermatologic
- •Neoplasms
- •Anorectal Conditions
- •Systemic Diseases
- •Physical Examination
- •Infectious
- •Dermatologic
- •Neoplasms
- •Biochemical Testing
- •Microbiology Testing
- •Patch Testing
- •Anoscopy: Proctoscopy
- •Biopsy
- •Evidence-Based Management
- •Primary Prutitis Ani
- •Secondary Prutitis Ani
- •Infectious
- •Dermatologic
- •Systemic Diseases
- •19: Sexually Transmitted Infections
- •Introduction
- •Perianal or Genital Lesions
- •Proctitis
- •Proctocolitis
- •Enteritis
- •Gonorrhea
- •Epidemiology
- •Clinical Presentation
- •Emerging Antibiotic Resistance
- •Chlamydia
- •Epidemiology
- •Clinical Presentation
- •Lymphogranuloma Venereum
- •Epidemiology
- •Clinical Presentation
- •Treatment
- •Syphilis
- •Epidemiology
- •Clinical Presentation
- •Testing Recommendations
- •Treatment
- •Chancroid
- •Granuloma Inguinale aka Donovanosis
- •Herpes
- •Epidemiology
- •Clinical Presentation
- •Treatment
- •Human Papillomavirus
- •Epidemiology
- •Clinical Presentation
- •Testing
- •Treatment
- •Vaccine
- •Epidemiology
- •Testing
- •Anorectal Issues
- •Molluscum Contagiosum
- •Pubic Lice: Phthirus pubis
- •Scabies
- •20: Anal Intraepithelial Neoplasia
- •Introduction
- •Symptoms
- •Epidemiology
- •Screening/Surveillance
- •Diagnosis
- •Treatment
- •Management Strategies
- •Progression
- •Prevention
- •21: Anal Cancer
- •Anal Squamous Cell Carcinoma
- •Anal Melanoma
- •Anal Adenocarcinoma
- •22: Presacral Tumors
- •General Considerations
- •Anatomic Considerations
- •Diagnosis
- •Management
- •Outcomes
- •Chromosomal Instability
- •Microsatellite Instability
- •CpG Island Methylator Phenotype (CIMP)
- •Adenomatous Polyposis Syndromes
- •Familial Adenomatous Polyposis
- •Clinical Presentation
- •Underlying Genetics
- •Diagnosis
- •CRC Risk
- •FAP Extracolonic Manifestations
- •Management
- •Screening
- •Treatment
- •Colorectal
- •Duodenal Adenomas
- •Desmoid Disease
- •Thyroid Neoplasia
- •MUTYH-Associated Polyposis
- •Clinical Presentation
- •Underlying Genetics
- •Diagnosis
- •CRC Risk
- •Extracolonic Cancer Risk
- •Management
- •Screening
- •Treatment
- •Polymerase Proofreading-Associated Polyposis
- •Hamartomatous Polyposis Syndromes
- •Juvenile Polyposis Syndrome
- •Clinical Presentation
- •Underlying Genetics
- •Diagnosis
- •Management
- •Screening
- •Treatment
- •Peutz-Jeghers Syndrome
- •Clinical Presentation
- •Underlying Genetics
- •Diagnosis
- •Management
- •Surveillance
- •Polypectomy
- •Surgery
- •PTEN Hamartoma Tumor Syndrome (PHTS)
- •Clinical Presentation
- •Underlying Genetics
- •Diagnosis
- •CRC Risk Management
- •Serrated Polyposis Syndrome (SPS)
- •Clinical Presentation
- •Underlying Genetics
- •Diagnosis
- •CRC Risk
- •Management
- •Screening
- •Treatment
- •Lynch Syndrome
- •Genotype-Phenotype Correlations
- •Muir-Torre Syndrome (MTS)
- •Turcot’s Syndrome
- •Colorectal Cancer Risk
- •Other LS-Associated Cancer Risk
- •Diagnosis
- •Individual Whose Family Meets Amsterdam Criteria but Does Not Have Any Clinical Phenotype
- •Clinical Management
- •Screening
- •Introduction
- •Recommended Screening Guidelines
- •Screening Cessation
- •Colonoscopy
- •Incomplete Colonoscopy
- •Complications
- •CT Colonography (CTC) or Virtual Colonoscopy
- •Flexible Sigmoidoscopy
- •Complications
- •Fecal Occult Blood Testing (FOBT)/Fecal Immunochemical Testing (FIT)
- •Stool DNA Testing
- •Double-Contrast Barium Enema (DCBE)
- •Surveillance
- •History
- •Adenoma
- •Hamartomas Polyps
- •Early Cancer (T1) Within Polyp
- •Chemoprevention
- •Background
- •Clinical Presentation
- •Preoperative Evaluation
- •Tumor Localization
- •Total Colon Evaluation
- •Carcinoembryonic Antigen (CEA)
- •Radiographic Evaluation
- •Lymph Node Evaluation
- •Lynch Syndrome Phenotype
- •26: The Surgical Management of Colon Cancer
- •Preoperative Preparation
- •Physiologic Assessment
- •Tumor Localization
- •Surgical Technique
- •Extent of Resection
- •Mesocolic Resection
- •Right Colectomy
- •Open Approach
- •Lateral-to-Medial Approach
- •Posterior (Inferior-to-Superior) Approach
- •Superior to Inferior Approach
- •Medial-to-Lateral Approach
- •Anastomosis
- •Laparoscopic Approach
- •Medial-to-Lateral Approach
- •Posterior (Inferior-to-Superior) Approach
- •Left Colectomy
- •Open
- •Anastomotic Assessment
- •Hand-Assisted Medial-to-Lateral Approach
- •Subtotal Colectomy
- •Open Approach
- •Laparoscopic Approach
- •Total Abdominal Colectomy with Ileorectal Anastomosis
- •Special Circumstances
- •Laparoscopy
- •Obstructing Colon Cancers
- •Perforated Colon Cancers
- •Management of Primary Colon Cancer in the Setting of Distant Metastasis
- •Outcomes for Colon Cancer
- •Short-Term Outcomes
- •Long-Term Outcomes
- •Introduction
- •Total Colon Evaluation
- •Locoregional Imaging
- •Computed Tomography
- •Endorectal Ultrasound
- •T Staging
- •N Staging
- •Magnetic Resonance
- •Whole-Body Imaging
- •Computed Tomography
- •Positron Emission Tomography (PET)
- •28: Rectal Cancer: Neoadjuvant Therapy
- •Introduction
- •Historical Context
- •Postoperative Radiotherapy
- •Preoperative Radiotherapy
- •Radiosensitizing Agents
- •Preoperative Versus Postoperative Radiation
- •Short- Versus Long-Course Preoperative Radiotherapy
- •Choosing Optimal Treatment Regimens
- •The European Approach
- •Selected Adjuvant Systemic Chemotherapy
- •Selective Nonoperative Management
- •Techniques
- •Results
- •Lymphovascular Invasion
- •Tumor Budding
- •Introduction
- •Neoadjuvant Chemoradiotherapy
- •31: Proctectomy
- •Pathological Assessment
- •Preoperative Preparation
- •Operative Approaches
- •Open Low Anterior Resection (LAR)
- •Laparoscopic Low Anterior Resection
- •Robotic Low Anterior Resection
- •Abdominoperineal Resection (APR)
- •Extralevator or “Cylindrical” APR
- •Special Considerations
- •Distal Margin
- •Coloanal Anastomosis
- •Fecal Diversion
- •Extended Resection
- •Intraoperative Radiation Therapy
- •Flap Closure Following Abdominoperineal Resection
- •Functional Outcomes
- •Oncologic Outcomes
- •Multidisciplinary Rectal Cancer Care
- •32: Rectal Cancer Decision-Making
- •Assessment
- •Early Rectal Neoplasms
- •Local Excision
- •Endoscopically Excised Malignant Polyps
- •Surgical Considerations
- •Intraoperative Decisions
- •Midrectal Cancers
- •Low Rectal Cancers
- •Low Hartmann Resection Versus APR
- •Special Situations
- •Obstructing Rectal Cancer
- •Perforated Rectal Cancer
- •Synchronous Hepatic Metastases
- •33: Colorectal Cancer: Postoperative Adjuvant Therapy
- •Colon Cancer
- •Stage III Colon Cancer
- •Stage II Colon Cancer
- •Rectal Cancer
- •Patients Who Did Not Undergo Neoadjuvant Therapy
- •Patients Who Underwent Neoadjuvant Radiotherapy/Chemoradiotherapy
- •Patients Undergoing Local Excision
- •34: Colorectal Cancer: Surveillance After Curative-Intent Therapy
- •Introduction
- •Physical Examination
- •Laboratory Testing
- •Abdominal Imaging
- •Chest Imaging
- •Colonoscopy
- •Stage 1 Disease
- •Cost
- •Introduction
- •Determining Resectability
- •Multimodal Therapy Including Intraoperative Radiation
- •General Considerations
- •Recurrent Colon Cancer
- •Recurrent Rectal Cancer
- •Recurrences that Extend Anteriorly
- •Resection that Includes Sacrectomy
- •Stage I: Anterior Component
- •Stage II: Posterior Component
- •Stage III: Spinal Reconstructive Component
- •Soft Tissue Reconstruction
- •Recurrent Colon Cancer
- •Recurrent Rectal Cancer
- •Sacropelvic Resections
- •Palliative Approach
- •Introduction
- •Diagnostic Strategies
- •Computed Tomography
- •Positron Emission Tomography (PET)
- •Magnetic Resonance Imaging
- •Contrast-Enhanced Ultrasound
- •Biopsy
- •Multidisciplinary Evaluation
- •Surgical Emergency
- •Self-Expanding Intraluminal Metal Stents
- •Liver-First Strategy
- •Colon-First Strategy
- •Margin Status
- •Other Liver Metastasis Strategies: Hepatic Intra-arterial Chemotherapy/Chemoembolization
- •Pulmonary Metastasis
- •Peritoneal Metastasis
- •Ovarian Metastases
- •Bone
- •Brain
- •Pancreas
- •Adrenal
- •Retroperitoneal Lymph Nodes
- •37: Appendiceal Neoplasms
- •Introduction
- •Epidemiology
- •Epithelial Neoplasms
- •Neuroendocrine Appendiceal Lesions/Carcinoid Tumors
- •Goblet Cell Carcinoids
- •Clinical Features
- •Diagnostic Procedures
- •Medical Management
- •Appendectomy
- •Right Hemicolectomy

16 Rectovaginal Fistula
223
29 patients in this trial had rectovaginal stulas and at week 14 of treatment, 13 of
those patients (44.8%) were found to have
healed stulas, Table16.1.
• Successful surgical treatment of Crohn’srelated RVF varies in the literature, with success rates ranging from 30% to 70%.
• Patients most likely to have a successful repair
are those with an isolated RVF without other
perianal disease and in whom their Crohn’s
disease is quiescent.
• Lufer etal.
– Forty-ve patients with Crohn’s-related
RVFs.
– Underwent a total of 95 interventions,
averaging 2.1 interventions per patient.
– Their long-term success rate was 53%.
– Ten patients (22.2%) required
proctectomy.
– Levatorplasty and endorectal advancement
aps – similar rates of success at approximately 50%.
• Hull and Fazio reported:
– Forty-eight Crohn’s patients with RVF.
– Nine required proctectomy and ve were
treated with a seton only.
– Of the 35 who underwent attempted deni-
tive repair, 19 were successful (54%).
• Five of the failures underwent subsequent successful procedures for an overall success rate of 24/35 (69%).
– Success was more likely among the patients
who had fecal stream diversion, with 8/9
diverted patients having successful repairs.
• El-Gazzaz etal.
– Sixty-ve women with Crohn’s disease
who underwent RVF repair
– Thirty successes (46.2%)
– Noted that many of the failures were late
failures and thus recommended long-term
follow-up
Evaluation ofaPatient
withaRectovaginal Fistula
• The etiology of the stula can often be determined from the patient’s history.
• On digital rectal examination, the condition of
the perineal body and rectovaginal septum
should be noted.
• Care should be taken to assess the quality and
strength of the anal sphincters.
• Careful palpation of the entire rectovaginal
Fig. 16.1 Large Crohn’s-related rectovaginal stula with
multiple external openings in the perineum
Table 16.1 Medical therapy for Crohn’s-related RVFs
Author Year of publication Drug utilized No. of patients No. of successful closures (%)
Present 1980 6-MP 6 2 (33.3)
Ricart 2001 Iniximab 15 5 (33.3)
Bodegraven 2002 Iniximab 4 0 (0)
Sands 2004 Iniximab 29 13 (44.8)
Parsi 2004 Iniximab 14 2 (14.2)
septum between the ngers of each hand may
reveal the presence of a small stula.

224
J. A. Cannon
• Note should also be made of any strictures or
scarring of the anal canal.
• The location of the stula relative to the
sphincter muscles and pelvic oor should be
determined as this can affect the type of repair
chosen.
• Differential:
– Colovaginal stula, rather than a rectovagi-
nal stula, from diverticulitis is a more
common condition.
– Very small or high RVFs may not be pal-
pable on exam.
• Imaging options include gastrografn enema
and vaginography.
– Low yield, however, and are rarely suc-
cessful in imaging distal stulas.
– They rely on occlusion of the anal canal or
vaginal introitus in order to generate
enough pressure to show passage of contrast through the stula, and balloon placement may occlude the stulous opening
itself.
– Figure 16.2 shows a RVF on gastrografn
enema.
• Endoanal ultrasound and MRI are the most
useful imaging studies to identify a stula.
– Figure 16.3 shows the appearance of a RVF
on MRI.
– Endoanal ultrasound has been reported to
identify the tract in 73% of patients.
• Injection of hydrogen peroxide through
the tract may aid in identication.
• Ultrasound is also useful in that it
enables assessment of the anal sphincters; following obstetric trauma, it can
evaluate sphincter damage.
• Patients with Crohn’s disease should undergo
a complete evaluation of their Crohn’s disease, to include colonoscopy and CT or MR
enterography.
– While the stula itself is rarely seen on
colonoscopy, colonoscopy allows for identication of active disease and other
Crohn’s-related complications. Figure16.4
demonstrates the appearance of an internal
opening on colonoscopy.
• The best option for identifying an occult RVF
is an examination under anesthesia.
– This allows for probing of the rectovaginal
septum with a stula probe to elucidate the
location (Fig.16.5).
– It also allows for inspection of the anal
canal and rectal and vaginal mucosa to
identify areas of inammation or dimpling
for more targeted inspection.
Fig. 16.2 Gastrografn enema showing contrast passing
through a rectovaginal stula. © 2015 Kobayashi and
Sugihara; licensee Springer. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/
by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work
is properly credited
Fig. 16.3 Rectovaginal stula as seen on MRI

16 Rectovaginal Fistula
Fig. 16.4 Rectovaginal stula on retroexed view on
colonoscopy. © 2015 Kobayashi and Sugihara; licensee
Springer. This is an Open Access article distributed under
the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly
credited
225
Fig. 16.6 With the patient in Trendelenburg position,
saline is placed in the vagina. An Asepto syringe is used to
inject air in the rectum. Bubbling in the vagina reveals the
location of the rectovaginal stula
Fig. 16.5 Fistula probe passing through a rectovaginal
stula
– The vagina can be lled with saline, while
the rectum is insufated with air
(Fig.16.6).
– Alternatively, a tampon or operative sponge
may be placed in the vagina, and saline
with methylene blue dye can be introduced
into the rectum, and blue staining on the
gauze within the vagina conrms that a stula is present.
Surgical Approaches toRepair
ofRectovaginal Fistulas
• For many patients, more than one attempt at
repair is necessary.
• For simple rectovaginal stulas (located in the
mid or lower vagina and without Crohn’s disease), 74% healing.
• For recurrent stulas of various etiologies,
healing 79–87%.
• For patients with Crohn’s, healing is only
44.2% per procedure, but 78% of patients
were eventually healed.
– Tobacco use was identied as a risk factor
for recurrence.
Endorectal Repairs
• Endorectal advancement aps are the most
commonly performed procedure for the management of a rectovaginal stula.

226
ab
cd
J. A. Cannon
• The procedure as described by Rothenberger
etal., in 1982, Fig.16.7:
1. The patient is placed in the jackknife prone
position.
2. A Pratt bivalve anoscope is used to expose
the anterior rectal wall.
3. Distal to the location of the stula, an
incision is made through the mucosa,
submucosa, and down to the internal
sphincter.
4. A ap including mucosa, submucosa, and
bers of the circular muscle (internal
sphincter) is raised in the rectum
proximally.
5. The ap is raised for a distance 4cm proximal to the location of the stula in order to
allow for a tension-free anastomosis.
6. Once the ap has been raised, the stula
itself is closed by approximating the bers
of the internal sphincter.
7. The distal most portion of the ap that contains the stula is excised.
8. The healthy ap is brought down to cover
the stula opening and secured in place.
Fig. 16.7 Endorectal advancement ap for rectovaginal
stula. Rectovaginal stula is seen from the anus (a). The
ap of mucosa, submucosa, and circular muscle is raised
(b). Circular muscle is sutured by horizontal mattress
manner (c). The ap is advanced over the repaired area
(d). The ap is sutured in place at its apex and along its
sides. © 2015 Kobayashi and Sugihara; licensee Springer.
This is an Open Access article distributed under the terms
of the Creative Commons Attribution License (http://cre-
ativecommons.org/licenses/by/4.0), which permits unre-
stricted use, distribution, and reproduction in any medium,
provided the original work is properly credited

16 Rectovaginal Fistula
Table 16.2 Endorectal advancement aps
Author Year of publication No. of patients No. of successful closures (%)
Rothenberger 1982 35 30(86)
Jones 1987 23 16 (70)
Lowry 1988 44 56 (78)
Watson 1995 12 7 (58)
Sonoda 2002 37 16 (43)
Ellis 2008 44 29 (66)
Hull 2011 37 23(62)
• The most common cause for failure is thought
to be ap retraction or necrosis.
– The base of the ap should be at least twice
the width of the apex of the ap in order to
ensure adequate blood supply.
• Rothenberger and Lowry reported overall
good success of 86–88%.
• Ellis reported a 66% success rate in 44
patients.
• Sonoda et al. reported success in 16/37
(43.2%).
• Hull and colleagues in 23/37 (62%).
• Available data on endorectal advancement
aps is summarized in Table16.2.
• Of note, the likelihood of a successful repair
Fig. 16.8 Transperineal repair where the rectum and
vagina have been separated and the defects in each are
visible
with an endorectal advancement ap decreases
if patients have undergone previous repairs
(30–55%).
• This may be done via levatorplasty or
sphincteroplasty.
• The repaired areas of rectum and vagina can
also be imbricated.
Transperineal Repairs
• A rectal advancement ap can be added to the
procedure.
• A number of variations in technique exist
including episioproctotomy with layered
closure, transperineal repair with levatorplasty, the LIFT procedure, and
sphincteroplasty.
• These procedures all begin with an incision in
the perineum that may be circumlinear around
the anus, transverse, or vertical.
• Dissection continues cephalad along the rectovaginal septum.
• The rectum and vagina are separated from one
another and the stula tract divided, as seen in
Fig.16.8.
• The incision is closed in layers. Ideally, some
tissue, preferentially muscle, is interposed
between the rectum and vagina.
• Athanasiadis and colleagues reported good
success with this technique in a Crohn’s population with 14/20 (70%) undergoing successful repairs.
• Lowry had success in 22 of 25 patients who
underwent a combined sphincteroplasty and
endorectal advancement ap (88%), which
was an improvement over the 78% success
with advancement ap alone.
• Hull and associates reported success in 39/50
patients who underwent a transperineal repair
(78%).
• The available data for transperineal repairs is
summarized in Table16.3.
• A transperineal repair with sphincteroplasty is
the most appropriate type of repair in women
227

228
Table 16.3 Transperineal repairs
Author Year of publication No. of patients No. of successful closures (%)
Athanasiadis 2007 20 14 (70)
Hull 2011 50 39(78)
Wiskind 1992 21 21(100)
who have a sphincter defect (most often from
obstetrical injury), as this is addressed
simultaneously.
Tissue Transposition Repairs
• Tissue transposition repairs offer the advantage of interposing healthy, well-perfused tissue between the rectum and vagina.
– Add bulk and physically increase the dis-
tance between the rectum
– Bring their own blood supply may aid in
healing
– Highest success rate of all transperineal
repairs
• Fecal diversion is generally performed prior to
or at the time of surgery.
• The labial fat pads with bulbocavernosus muscle (Martius ap) or gracilis muscle transposition are the most commonly used tissues.
• Use of other muscles including the sartorius
and gluteal muscle has also been described.
Fig. 16.9 Martius ap repair. The vaginal ap has been
raised revealing the rectovaginal stula. (Courtesy of Drs.
Eric Johnson and Scott Steele)
J. A. Cannon
Martius Flap
The Martius ap uses the bulbocavernosus muscle and labial fat pad for transposition.
1. The initial incision is made in the vaginal
introitus distal to the stula opening in order
to expose the rectovaginal septum.
2. Dissection continues in the rectovaginal sep-
tum cephalad to the stula (Fig.16.9).
3. The stula tract is curetted and closed pri-
marily on the rectal side.
4. The vaginal portion of the stula is excised
from the vaginal ap.
5. In order to harvest the donor tissue, a vertical
incision is made in the labia majora
(Fig.16.10).
6. The labial fat pad and underlying bulbocav-
ernosus muscle are dissected out from the
surrounding tissues.
Fig. 16.10 Martius ap repair. Incision over the left labia
majora to expose the fat pad and bulbocavernosus.
(Courtesy of Drs. Eric Johnson and Scott Steele)
7. The blood supply to the ap comes in inferiorly and posteriorly from the posterior labial
vessels.
8. The ap is transected superiorly and tunneled to the rectovaginal septum. It should
be rotated carefully so as not to kink the
blood supply (Figs.16.11 and 16.12).
9. The ap is laid within the RV septum and the
vaginal ap sutured over the Martius ap
(Fig.16.13).

16 Rectovaginal Fistula
Fig. 16.11 Martius ap. A tunnel is created from the origin of the bulbocavernosus to the vaginal incision.
(Courtesy of Drs. Eric Johnson and Scott Steele)
229
Fig. 16.14 Appearance after the Martius ap. (Courtesy
of Drs. Eric Johnson and Scott Steele)
Table 16.4 Martius ap
Author
White 1982 14 13(93)
Aartsen 1988 14 13(93)
McNevin 2007 16 15(94)
Sogne 2007 14 13(93)
Pitel 2011 23 15(65)
Kniery 2015 5 3 (60)
Year of
publication
No. of
patients
No. of successful
closures (%)
Fig. 16.12 Martius ap. The donor tissue has been
brought into the rectovaginal septum. (Courtesy of Drs.
Eric Johnson and Scott Steele)
Fig. 16.13 Martius ap. The vaginal incision has been
closed over the Martius ap. (Courtesy of Drs. Eric
Johnson and Scott Steele)
10. Figure 16.14 shows the postoperative
appearance.
• The largest case series using the Martius
ap was published by Pitel et al., in
2011.
– They reported a 65% success rate in
23 patients.
• The available data is summarized in
Table16.4.
Gracilis Muscle Transposition
• Advantage of providing a large bulk of wellvascularized muscle to separate the vagina
and rectum.
• Higher morbidity due to the mobilization and
transposition of this large muscle.
• Fecal diversion is generally performed prior to
or at the time of the procedure.

230
J. A. Cannon
The operation involves:
1. Transperineal incision (Fig.16.15), in which
the rectum and vagina are separated. The stula is divided and both the rectum and vagina
are closed primarily.
2. Dissection should continue cephalad to the
stula until healthy tissue is reached.
3. An endorectal advancement ap can be added
to the procedure as well.
4. The gracilis muscle is then harvested with
either a long incision of the length of the gracilis or with separate smaller incisions near the
muscle’s origin and insertion.
5. The muscle is mobilized with division of the
perforating vessels.
6. It is divided just above its insertion.
7. It is tunneled from the proximal most portion
of the incision to the perineal incision, as seen
in Fig.16.16.
8. The muscle is secured to the apex of the rectovaginal dissection and the transperineal incision closed, as seen in Fig.16.17.
• Reported success rates range from 47%
(36)
to 92%; Table16.5 summarizes the available data.
Fig. 16.16 Gracilis transposition. The gracilis muscle
has been tunneled from the left thigh to the transperineal
incision. (Courtesy of Drs. Jamie Cannon, Andre
Levesque, and James Long)
Fig. 16.15 Gracilis transposition. A transperineal incision is made to separate the rectum and the vagina.
(Courtesy of Drs. Jamie Cannon, Andre Levesque, and
James Long)
Fig. 16.17 Gracilis transposition. Postoperative appearance. (Courtesy of Drs. Jamie Cannon, Andre Levesque,
and James Long)
Table 16.5 Gracilis muscle transposition
Author
Furst 2008 12 11 (92)
Wexner 2008 17 9 (53)
Lefevre 2009 8 6 (75)
Pinto 2010 24 19 (79)
Year of
publication
No. of
patients
No. of successful
closures (%)

16 Rectovaginal Fistula
231
Transvaginal Repairs
• Transvaginal repairs are usually found more
often in the gynecologic literature.
• Relative ease and better exposure gained
through the vagina as compared to the anus.
• The rectum is the higher-pressure side of the
stula, so transvaginal repairs should involve
closure of the rectum and not just of the
vagina.
• Sher etal. report on the use of a transvaginal
ap for Crohn’s-related RVF.
– All patients had fecal diversion.
– 13/14 patients healed (93%).
Transabdominal Repair
• Generally reserved for stulas that are located
in the mid rectum with an internal opening at
the fornix of the vagina.
• Involves a low anterior resection, where the
segment of the rectum containing the stula is
resected and a colorectal or coloanal anastomosis performed.
• The vaginal side of the defect can be closed
primarily.
• Van der Hagen and colleagues reported laparoscopically separating the rectum and vagina
and repairing each primarily.
– Omentum was mobilized and laid in-
between the rectum and the vagina.
– Reported successful repair in 38/40 patients.
Alternate Repairs
• Fistula plug has been described but should be
limited to those with a long-tract RVF.
– The plug is brought from the rectal to vagi-
nal side, excess length on the plug is
trimmed, and it is sutured in place with
absorbable suture.
– 44–86% success.
• Injection of fat into the tissue surrounding the
stula.
• Transanal endoscopic microsurgical (TEMS)
approach.
Choice ofTechnique forRepair
• In deciding on a surgical approach, the surgeon should evaluate the patient for continuing inammation or ongoing pelvic sepsis.
– These must be controlled prior to surgical
repair, or the chance of success is dismal.
• Abscess drainage, antibiotics, and seton
placement until resolved
– Treatment with anti-TNF agents should be
considered preoperatively in all patients
with Crohn’s disease.
• Not all patients with Crohn’s disease
and RVF will be candidates for repair.
• If this is not possible, non-cutting seton
placement can be a long-term method of
controlling symptoms.
• Proctectomy is considered for those
with severe disease.
• The surgeon must also decide whether preoperative diversion is indicated.
– Has not been shown to decrease the rate of
stula recurrence, although this may well
be because the patients that undergo fecal
diversion have more complicated disease.
– When low rates of success are anticipated
(e.g., multiple prior repairs, poor tissue
compliance), preoperative fecal diversion
should be considered.
– Patients undergoing major transabdominal
resections, or muscle transposition procedures, should have fecal diversion.
• The anatomic location of the stula will dictate a local repair versus a transabdominal
approach (mid rectum and upper vagina).
• For local repairs, the quality of the patient’s
tissue should be assessed.
– If the patient’s tissues are healthy, have
normal compliance, and lack scarring, an
endorectal advancement ap is an appropriate rst approach.
– If the RVF is secondary to obstetric injury
and a sphincter defect is also present, a
transperineal repair with sphincteroplasty
is performed.
– A transperineal approach should be consid-
ered in those who have failed previous
endoanal advancement aps.

232
High fistulas
Trans-
abdominal
repair
Abscess
drainage,
setons as
needed
Yes
Muscle
transposition
repair
Medical management,
infliximab, seton,
proctectomy as needed
for symptom control
Yes
No
Success? Yes
Transperineal
repair with
sphincteroplasty
Yes
J. A. Cannon
No
Success?
Endorectal
advancement
flap
Low to mid
fistulas
Perianal sepsis?
No
Active Crohn’s
Yes
No
Fig. 16.18 Algorithm for management of rectovaginal stulas
– For either endoanal advancement aps or
transperineal repairs, the surgeon may also
consider the use of biologic grafts to reinforce the repair.
– If the local tissues are not adequate for
repair, then transposition of healthy tissue
should be considered.
repair
Sphincter
defect?
Yes
No
Muscle
transposition
disease?
Success?
No
Health tissue
without previous
repairs?
Transperineal
• The most common tissues used for
transposition are the Martius ap or
gracilis muscle. Figure 16.18 provides
an algorithm that summarizes the above
recommendations.
No
repair
Соседние файлы в папке Библиотека им академика М.И. Перельмана
